Wire Stories

Tourism and Hotel Market in Indonesia to Expand by $21.93 Billion Through 2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Tourism and Hotel Market in Indonesia 2022-2026" report has been added to ResearchAndMarkets.com's…

Australia Cold Chain Logistics Market Report 2022-2027: Demand For Red Meat & Increasing Population Driving 3% Annual Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Cold Chain Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022…

Westwater Resources Applauds the Inflation Reduction Act’s Support for Domestic Production of Battery Materials

Kellyton Graphite Plant Output Should Directly Benefit from the Production Tax Credit Coosa Graphite Deposit…

Epoxy Resin Markets in China: Demand to Grow by 7% Through 2031 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Epoxy Resin Markets in China" report has been added to ResearchAndMarkets.com's offering. China's…

Asia-Pacific Base Oil Market Report 2022-2028: Rising Demand for High-Grade Oils from the Automotive Sector & Wide Range of Applications Across Different End-Users Driving Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Base Oil Market 2022-2028" report has been added to ResearchAndMarkets.com's offering. MARKET…

Kyowa Kirin Receives European Commission Approval for Use of CRYSVITA®?(burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)

CRYSVITA is the first approved biologic treatment in the EU for patients with TIO who…

E.SUN ESG and Sustainability Initiative Gains Greater Influence Through 100+ Outstanding Enterprises

TAIPEI,Taiwan--(BUSINESS WIRE)--E.SUN Bank today convened a conference on “E.SUN ESG and Sustainability Initiative.” President Ms.…

Elliptic Labs Signs License Agreement with a New Smartphone Customer

OSLO, Norway--(BUSINESS WIRE)--#AIVirtualProximitySensor--Elliptic Labs (OSE: ELABS), a global AI software company and the world leader…

Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022

Kapruvia® (difelikefalin) is the first and only therapy approved through consortium filing for the treatment…